High expression of TGF-b1 in the vaginal incisional margin predicts poor prognosis in patients with stage Ib-IIa cervical squamous cell carcinoma

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 3925-3931

  Fan, Dong Mei ^a   Wang, Xin Jun ^b   He, Tao ^a   Wang, Yan ^a   Zhou, Dan ^a   Kong, Guo Qiang ^a   Jiang, Tao ^a   Zhang, Mei Mei ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cervical squamous cell carcinoma (CSCC); Prognosis; TGF b1; Vaginal incisional margin

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UTERINE CERVIX CARCINOMA; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 84863006336     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1171-x     Document Type: Article

References (18)

1. Moore MA, Tajima K, Anh PH, Aydemir G, Basu PS, Bhurgri Y, Chen K, Gajalakshmi V, Hirose K, Jarrahi AM, le Ngoan T, Qiao YL, Shin HR, Sriamporn S, Srivatanakul P, Tokudome S, Yoo KY, Tsuda H (2003) Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world. Asian Pac J Cancer Prev 4: 153-165
2. Umezulike AC, Tabansi SN, Ewunonu HA, Nwana EJ (2007) Epidemiological characteristics of carcinoma of the cervix in the Federal capital Territory of Nigeria. Niger J Clin Pract 10:143-146
3. Ronco G, Anttila A (2009) Cervical cancer screening in Europe-changes over the last 9 years. Eur J Cancer 45:2629-2631
4. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995-2004
5. Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B, Spandidos DA (2007) Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: Implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 31:69-79
6. Li Q, Huang W, Zhou X (2009) Expression of CD34, alpha-smooth muscle actin and transforming growth factor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix. J Int Med Res 37:446-454
7. Deng W, Tsao SW, Kwok YK, Wong E, Huang XR, Liu S, Tsang CM, Ngan HY, Cheung AN, Lan HY, Guan XY, Cheung AL (2008) Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. Cancer Res 68:7200-7209
8. Hazelbag S, Kenter GG, Gorter A, Fleuren GJ (2004) Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer. Int J Cancer 112:1020-1028
9. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC (1997) Overexpression of P34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc 72:925-929
10. Vujkov T, Zivaljević M, Novaković P, Erak M, Rajović J, Mandić A (2002) Treatment protocol for CSCC. Med Pregl 55:105-108
11. Watari H, Xiong Y, Hassan MK, Sakuragi N (2009) Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype. Gynecol Oncol 112:229-234
12. Peralta-Zaragoza O, Bermúdez-Morales V, Gutiérrez- Xicotencatl L, Alcocer-González J, Recillas-Targa F, Madrid-Marina V (2006) E6 and E7 oncoproteins from human papillomavirus type induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence. Viral Immunol 19:468-480
13. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK (2010) MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29:5741-5754
14. Kuroishi S, Suda T, Fujisawa T, Ide K, Inui N, Nakamura Y, Nakamura H, Chida K (2009) Epithelial-mesenchymal transition induced by transforming growth factor-beta1 in mouse tracheal epithelial cells. Respirology 14:828-837
15. Yi J, Hur K, Lee E, Jin YJ, Arteaga CL, Son YS (2002) TGFbeta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol 81:457-468
16. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK (2009) Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol 32:411-416
17. Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y (2007) Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy. Gynecol Oncol 105:757-761
18. Yang Y-C, Wang K-L, Su T-H, Liao H-F, Wu M-H, Chen T-C, Huang M-C, Chen Y-J (2006) Concurrent cisplatin-based chemoradiation for cervical carcinoma: Tumor response, toxicity, and serum cytokine profiles. Cancer Invest 24:390-395